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Cellular differentiation is regulated by the strict spatial and temporal control of gene
expression. This is achieved, in part, by regulating changes in histone post-translational
modiﬁcations (PTMs) and DNA methylation that in turn, impact transcriptional activity.
Further, histone PTMs and DNA methylation are often propagated faithfully at cell division
(termed epigenetic propagation), and thus contribute to maintaining cellular identity in
the absence of signals driving differentiation. Cardinal features of adaptiveT cell immunity
include the ability to differentiate in response to infection, resulting in acquisition of immune
functions required for pathogen clearance; and the ability to maintain this functional
capacity in the long-term, allowing more rapid and effective pathogen elimination following
re-infection. These characteristics underpin vaccination strategies by effectively establish-
ing a long-lived T cell population that contributes to an immunologically protective state
(termed immunological memory ). As we discuss in this review, epigenetic mechanisms
provide attractive and powerful explanations for key aspects ofT cell-mediated immunity –
most obviously and notably, immunological memory, because of the capacity of epigenetic
circuits to perpetuate cellular identities in the absence of the initial signals that drive
differentiation. Indeed,T cell responses to infection are an ideal model system for studying
how epigenetic factors shape cellular differentiation and development generally.This review
will examine how epigenetic mechanisms regulate T cell function and differentiation, and
how these model systems are providing general insights into the epigenetic regulation of
gene transcription during cellular differentiation.
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INTRODUCTION
Protection from themyriad of infectious pathogenswe are exposed
to on a daily basis largely results from the coordinated interaction
of the cells and molecules of the mammalian immune system.
Key cellular components of the adaptive immune system are white
blood cells (lymphocytes) of which there are two types: B and T
cells. B andT cells share features of adaptive immunity that include
the ability to recognize pathogen components via clonal expression
of a unique cell surface receptor; the ability to rapidly proliferate
upon recognition of a pathogen, coincident with acquisition of
cell lineage-speciﬁc immune functions; and ﬁnally, the ability to
persist after the infection is cleared, combined with the capac-
ity to “remember” the pathogen and respond more rapidly and
vigorously upon re-infection (termed immunological memory).
T cells can be further divided into helper T (TH) cells and
cytotoxic (killer) T cells. TH cells are distinguished by cell sur-
face expression of CD4 (i.e. CD4+ T cells) and promote effective
immunity by secreting molecules that promote effective antibody
and cellular responses upon infection. Further, TH cells can differ-
entiate into at least six subtypes, each characterized by expression
of different immune molecules (termed effector molecules), which
in turn, dictates that each TH subset can play a different role in
immunity to infection. In contrast, killer T cells, distinguished
by cell surface expression of CD8 (i.e., CD8+ T cells), are the
“hit-men” of the immune system, typically locating and destroy-
ing virus-infected host cells, and thus limiting and contributing to
the eventual clearance of infection. Killer T cells express a range
of effector molecules that equip them to mediate this signature
killing capacity.
A cardinal feature of T cell immunity is the ability of naïve T
cells to undergo a program of proliferation and functional dif-
ferentiation upon activation, resulting in a large pool of cells,
all capable of recognizing a particular pathogen, and that have
acquired the immune functions necessary to control and eventu-
ally clear infection (Kaech et al., 2002; van Stipdonk et al., 2003;
Figure 1). Once an infection is cleared, the majority of the
expanded effector T cell population dies, leaving behind a small
pool of long-lived cells that can recognize the same pathogen that
triggered their initial activation (termed memory T cells; Marshall
et al., 2001; Kaech et al., 2002; La Gruta et al., 2004). Impor-
tantly, these memory T cells produce a broader array of immune
molecules than naïve cells, and in larger quantities, and unlike
naïve cells, can respond to infection without the need for further
differentiation (Lalvani et al., 1997; Agarwal and Rao, 1998; Oehen
and Brduscha-Riem, 1998; Veiga-Fernandes et al., 2000). These
features, combined with persistence at a higher frequency, enable
memory T cells to respond more rapidly upon secondary infec-
tion, enabling earlier control and clearance of infection (Figure 1),
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FIGURE 1 | Kinetics of CD8+ T cell differentiation following viral
infection. Shown is a typical CD8+ T cell response to a acute viral
infection. Antigen presenting cells (APC) present viral antigens to CD8+
T cells. This initiates a program of clonal expansion and differentiation
into effector CD8+ T cells capable of lineage-speciﬁc effector functions,
including the ability to secrete pro-inﬂammatory (TNF-α, IFN-γ) and
cytotoxic (perforin, granzyme) molecules. Following viral clearance, the
CD8+ T cells undergo an extensive contraction phase, mediated by
programed cell death. The remaining memory CD8+ T cells can persist
in the host for years. In the event of a secondary exposure to the
same virus, memory CD8+ T cells can rapidly expand and acquire
effector functions.
and together, these features of memory T cells provide the basis of
T cell-mediated immunity. Importantly, our understanding of the
molecular factors that shape cell fate decisions and drive acquisi-
tion of T cell effector function is limited, and questions remaining
to be determined include how a T cell decides to be a memory
versus an effector cell, and what are the molecular mechanisms
that enable stable maintenance of rapid effector function within
memory T cells in the long-term? In this review we describe what
we think are some of the more interesting and important studies
addressing these and similar questions, with the aim of demon-
strating the utility of the immune system as a tool for studying
epigenetics and cellular differentiation. We start by discussing
the diversity of T cells phenotypes, before describing our current
understanding of how epigenetic regulation inﬂuences how these
distinct functional T cell populations arise and are maintained.
DEFINING THE DIFFERING ROLES OF DISTINCT T CELL
SUBSETS IN MEDIATING IMMUNITY
An important feature of T cell immunity is the enormous prolifer-
ative potential and functional plasticity of naïveT cells. Acquisition
of lineage-speciﬁc T cell effector functions is clearly linked to
an extended proliferative response, suggesting that T cell activa-
tion engages a differentiation program that facilitates effector gene
expression (Gett and Hodgkin, 1998; Lawrence and Braciale, 2004;
Jenkins et al., 2008). An example of T cell functional plasticity
is found after activation of naïve TH cells that have the poten-
tial to differentiate into distinct T cell subsets, largely deﬁned by
the soluble effector molecules they secrete (Figure 2; Zhu et al.,
2010). The best characterized of these are the TH1 and TH2 sub-
sets, however, other subsets include TH17, Tregs (regulatory T
cells), TFH (follicular TH cells) and the more recently described
TH9 cells (Figure 2). TH1 and TH2 T cells are best character-
ized by their capacity to secrete interferon-gamma (IFN-γ) and
interleukin (IL)-4, respectively. The tailoring of TH cell responses
into distinct functional lineages is a consequence of integration
of multiple signals that are present during initial T cell activation
(Figure 2). For example, naïve TH cell activation in the presence of
the pro-inﬂammatory molecules, IFN-γ and IL-12, induces TH1
differentiation while IL-4 is a potent inducer of TH2 differenti-
ation (Zhu et al., 2010). Importantly, induction of transcription
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FIGURE 2 | CD4+ TH – cell subset differentiation. CD4+ T cells show
remarkable plasticity and are able to differentiate into many different
subsets based on the soluble molecules secreted during priming of the
subsets by antigen presenting cells (APC), e.g., IL-12 for TH1 cells. The
different subsets can be distinguished by the transcription factors that
regulate and maintain their lineage-speciﬁc effector functions, e.g., T-bet for
TH1 cells. The molecules secreted by these subsets, e.g., IFN-γ for TH1
cells, are ﬁnely tuned to control the pathogen that mediated the release of
the speciﬁc molecules by the APC during activation of theTH0 cells into the
various subsets.
factor (TF) expression by extracellular signals received by activated
TH cells drives T cell differentiation (Kanno et al., 2012); TH1 dif-
ferentiation is dependent on STAT1 activation and expression of
the T-box TF Tbx21 (T-bet; Djuretic et al., 2007). Conversely, IL-4
signals activate STAT6 resulting in up-regulation of the TF Gata3
(Ansel et al., 2003). TH17 differentiation is associatedwith IL-6/IL-
21 induced expression of the RORγT TF (Dong, 2008) and Treg
differentiation with FoxP3 (reviewed in Josefowicz et al., 2012).
Such is the importance of these TFs in directing naïve TH cell
commitment to a speciﬁc lineage that they are used as deﬁnitive
markers of TH subset differentiation (Figure 2).
As we learn more about these TH subsets, it is clear that there is
heterogeneity of effector function within a responding T cell pop-
ulation such that no one immune response is uniquely represented
by a single TH subset. Rather, there is tailoring of the total T cell
population such that a particular subset may be over-represented.
For example, TH1 type cells dominate the response to extracel-
lular bacterial infections, and in this case, expression of the TH1
cytokine, IFN-γ, is required to promote immune control of these
particular pathogens. In this way, the immune system ensures that
the most appropriate immune response is engaged to promote
control of infection.
Killer T cells contribute to the control and eventual elimina-
tion of intracellular bacteria, viruses and tumor challenges via
the coordinated interplay of varied effector mechanisms (Russ
et al., 2012). This includes the production of pro-inﬂammatory
cytokines such as IFN-γ and tumor necrosis factor alpha (TNF-
α; La Gruta et al., 2004) and the expression of cytolytic effector
molecules including perforin (Pfp; Kagi et al., 1994) and the gran-
ule enzymes (granzymes, Gzm) A, B, and K (Jenkins et al., 2007;
Peixoto et al., 2007; Moffat et al., 2009). Whilst killer T cells are
not typically associated with commitment to distinct lineages, it
is clear that speciﬁc TFs are also important in regulating their
differentiation and acquisition of effector function. For instance,
two T-box TFs, T-bet (encoded by Tbx21) and Eomesodermin
(encoded by Eomes; Intlekofer et al., 2005) play essential roles in
effector CTL differentiation. Analogous to its role in TH1 T cells,
T-bet is rapidly up-regulated upon naïve killer T cell activation
and directly regulates the rapid acquisition of IFN-γ produc-
tion (Cruz-Guilloty et al., 2009). Eomesodermin, a homolog of
T-bet, was originally implicated in the regulation of CD8+ T
cell granzyme B expression (Pearce et al., 2003), however, recent
studies suggest that Eomesodermin is expressed later during CTL
differentiation and contributes more to acquisition of perforin
expression, while helping sustain the capacity to express IFN-γ
(Cruz-Guilloty et al., 2009). IL-2 is a cytokine required for induc-
ing proliferation and survival of activated T cells (Miyazaki et al.,
1995). Importantly, high levels of IL-2 signaling at the timeof killer
T cell activation contribute to granzyme B and perforin expression
via STAT5 activation (Janas et al., 2005; Pipkin et al., 2010). In this
way, killer T cells integrate signals delivered by extrinsic inﬂam-
matory and survival signals during infection that promote effector
T cell differentiation.
While the importance of these TFs in lineage determination
is clear, exactly how they convey their effects on T cell differ-
entiation is less well understood. As we describe below, at least
some of these TFs (i.e., STAT6 and T-bet) exert their effects on T
cell differentiation through the recruitment of chromatin modi-
fying enzymes to the sites of TF binding (Lewis et al., 2007; Miller
et al., 2010; Onodera et al., 2010). Further, such mechanisms of
TF action are known from other systems, suggesting that this
mechanism may be common. Thus it appears that TFs and chro-
matin modifying enzymes cooperate, with the former providing
the DNA binding speciﬁcity, and the latter the catalytic activ-
ity. As described below, once modiﬁed, the chromatin can then
serve as a substrate for yet other protein complexes that physically
rearrange the chromatin, making it more or less permissive for
transcription.
EPIGENETIC REGULATION OF CELLULAR DIFFERENTIATION
Cellular differentiation is regulated by the strict spatial and tem-
poral control of gene expression, which at the most fundamental
level, is controlled by modulating access of the transcriptional
machinery to gene regulatory regions, including promoters and
enhancers. In eukaryotic cells, transcription occurs in the context
of chromatin – a complex formed between the genome and his-
tone protein octomers (termed nucleosomes), around which the
DNA is wound. As the intimate nature of the nucleosome–DNA
interaction can occlude binding of the transcriptional machinery,
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preventing transcription, this interactionmust be tightly regulated
to allow appropriate gene expression; this is achieved by con-
trolling the positioning of nucleosomes, and by modulating
their afﬁnity for DNA. Histone post-translational modiﬁcations
(PTMs) are key regulators of changes in chromatin structure that
then inﬂuence gene expression. Importantly, these modiﬁcations
are often propagated faithfully at cell division (termed epige-
netic propagation), maintaining cellular identity in the absence
of signals driving cellular differentiation.
Histone PTMs occur primarily at the solvent exposed N-
termini, and can take a number of forms, including acetylation,
methylation, and ubiquitination (Kouzarides, 2007). The tran-
scriptional consequences of these modiﬁcations are then mani-
fested either due to the direct biophysical consequences of the
modiﬁcation, or through the catalytic activities of proteins and
protein complexes that recognize and bind modiﬁed histones. For
instance, acetylation, which reduces the net positive charge on
the nucleosome, results in decreased stability of histone associa-
tions with the negatively charged DNA, promoting transcription.
Therefore, by balancing the expression and genomic localiza-
tion of histone acetyltransferases (HATs) and histone deacetylases
(HDACs), which add and remove acetyl groups, respectively, tran-
scription can be activated or repressed (reviewed in Bannister
and Kouzarides, 2011). Alternatively, it appears that the effects
of histone methylation are conveyed indirectly, with methylated
histones serving as a substrate for protein complexes that bind
and reconﬁgure the chromatin. Importantly, histone methyla-
tion is associated with both active and repressed transcription,
depending on the residuemethylated. For example, trimethylation
of lysine 4 of histone H3 (H3K4me3) is enriched at promot-
ers of many actively transcribed genes, while trimethylation
of lysine 27 of H3 (H3K27me3) is associated with transcrip-
tionally repressed genes (Barski et al., 2007; Wang et al., 2008;
Ernst et al., 2011).
Interestingly, activating and repressive modiﬁcations can co-
localize, even occurring on the same nucleosome, and it appears
that the combination and balance of these modiﬁcations serves
to tune levels of transcription (Wang et al., 2008). Importantly in
the context of cellular differentiation, co-localization of oppos-
ing PTMs is also employed to poise genes for rapid activation or
repression (Bernstein et al., 2006).
As well as controlling access of the transcriptional machin-
ery to the DNA template by modulating nucleosome positioning,
transcription is controlled epigenetically by changing the struc-
ture of the DNA itself, through the addition and removal of
bulky methyl groups. DNA methylation occurs predominantly
at cytosine residues occurring in the context of cytosine–guanine
di-nucleotides (termedCpGmethylation), and results in transcrip-
tional repression, both through steric hindrance of transcriptional
activator binding (as described below for FoxP3), and through
recruitment of methyl-CpG-binding domain proteins (MBD),
that in turn, recruit HDACs. For instance, MBD2 has been shown
to directly recruit HDAC1, resulting in histone deacetylation, and
transcriptional repression (Ng and Bird, 1999). Thus, CpG methy-
lation does not represent a separate systemof epigenetic regulation
to that described for histone PTMs, but rather is part of the same,
inter-connected system.
EPIGENETIC CONTROL OF CD8+ T CELL EFFECTOR FUNCTION
The function of CD8+ killer T cells is deﬁned largely by their
capacity to produce effector molecules such as anti-viral cytokines
and cytolytic molecules. As with naïve TH cells, the Ifng locus
of naïve CD8+ killer T cells is heavily marked by the repres-
sive H3K27me3, with little or none of the permissive H3K9Ac or
H3K4me3 PTMs (Denton et al., 2011). Upon differentiation from
naïve to effector killer T cells, transcriptional activation of Ifng
is associated with removal of H3K27me3 and deposition of the
permissive H3K9Ac and H3K4me3 PTMs (Denton et al., 2011).
Further, in effector CD8+ killer T cells, the Ifng locus had reduced
levels of total histone H3, indicating nucleosome evacuation from
the region, presumably to allow the transcriptional machinery
to access the promoter. Taken together, these data suggest that
reconﬁguration of the chromatin structure within naïve cells is
necessary to enable Ifng transcription. Moreover, there appears
to be conservation of chromatin restructuring and histone PTM
modiﬁcation with a similar pattern observed within other effec-
tor gene loci such as granzyme B (Gzmb; Juelich et al., 2009) and
granzyme A (Gzma; Lauren Hatton, Michelle Nguyen, Brendan
Russ, and Stephen Turner, data not shown).
As mentioned earlier, memory T cells maintain the capacity for
rapid effector gene expression without the need for further dif-
ferentiation. Strikingly, the permissive signature within the Ifng
promoter of effector CD8+ killer T cells is maintained into long-
term memory. Further, although memory CD8+ killer T cells
exhibit little Ifng transcriptional activity prior to re-infection,RNA
polymerase (RNAp) is docked at the Ifng promoter (Denton et al.,
2011; Zediak et al., 2011). Taken together, these data suggest that
the ability of memory cells to produce IFN-γ rapidly following
re-infection is due to the promoter being maintained in a tran-
scriptionally permissive state, and that the rate-limiting step in
re-expressionof IFN-γ is transcriptional initiation (Figures 3A,B).
It remains to be determined whether transcriptional poising (as
measured by RNAp docking) at other effector gene loci with low
transcriptionally activity is evident within memory CD8+ killer T
cells. Further, it would be of particular interest to determine the
extent of transcriptional poising in memory T cells at a genome-
wide level and compare this tonaïve and effector cells. In thisway, it
coulddetermined towhat extent transcriptional poisingunderpins
memory T cell characteristics. Moreover, given the direct effect of
acetylation on nucleosome density, increased acetylation in mem-
ory cells (Araki et al., 2008; Denton et al., 2011) may explain their
ability to produce more IFN-γ upon re-infection (La Gruta et al.,
2004). In this way, memory T cells are reconﬁgured at the chro-
matin level to exhibit more potent effector function and this, in
turn, helps ensure more effective and more rapid control of a
secondary infection.
Recently, Scharer et al. (2013) applied global approaches to
compare CpG methylation in naïve and effector CD8+ T cells.
Combining immunoprecipitation of methylated genomic regions
with high-throughput sequencing (MeDIP-seq), they identiﬁed
∼650,000 regions that were differentially methylated between
the two populations, indicating the likely importance of CpG
methylation as a means of regulating CD8+ T cell differentiation.
As expected, CpG methylation of gene promoters was inversely
correlated with gene transcription, but interestingly, ∼40% of
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FIGURE 3 | Bivalency of master regulator gene loci inTH1 andTH2 cells.
Prior to differentiation of TH0 cells into theTH1 or TH2 cell subsets, the
master regulator loci of each subset,Tbx21 and Gata3 respectively, have both
active H3K4me3 and repressive H3K27me3 marks. The bivalentTbx21 locus
loses the repressive H3K27me3 mark upon differentiation into TH1 cells.
However, the Gata3 locus remains bivalent. The reverse is true for TH2 cells
whereby Gata3 loses the repressive H3K27me3 mark yet retains bivalency at
theTbx21 locus.
genomic regions that differed in methylation state between naïve
and effector occurred away from gene promoters. Further analysis
showed that these promoter-distal regions largely overlapped can-
didate transcriptional enhancers identiﬁed in developing T cells
in the thymus using next-generation sequencing and chromatin
immunoprecipitation (ChIP-Seq) for enhancer-enriched histone
PTMs (H3K27Ac and H3K4me1). Finally, when these putative
enhancers were surveyed for over-represented TF binding sites,
known and putative transcriptional regulators of CD8+ T cell dif-
ferentiation were identiﬁed. Therefore, it seems likely that CpG
methylation is employed to regulate CD8+ T cell differentiation,
both by inﬂuencing protein–DNA interactions at gene promoters,
and at transcriptional enhancers. Further, this study highlights
the utility of such approaches in the identiﬁcation of regulatory
circuits controlling cellular differentiation.
CD4+ T CELL DIFFERENTIATION: A MODEL FOR
UNDERSTANDING EPIGENETIC REGULATION
The fact that distinct signals are capable of driving naïve TH cell
differentiation in vitro intowell-deﬁned subsetsmakesCD4+ Tcell
activation a useful model for understanding how epigenetic regu-
lation can inﬂuence cellular differentiation and fate determination.
Comparison of the epigenetic proﬁles of signature effector gene
loci within TH1 andTH2 cells has been particularly informative. In
response to TH1 differentiation signals, the IFN-γ locus of naïve
TH cells is remodeled to a permissive epigenetic signature that
reinforces and heritably maintains IFN-γ gene expression in the
long-term. At the same time, the IL-4 locus is remodeled to have
a repressive epigenetic signature resulting in the shutdown of IL-4
gene expression.
Recent work using ChIP-Seq has been instrumental in pro-
viding genome-level insights into how epigenetic processes might
regulate TH cell fate selection. For instance, genome-wide com-
parison of H3K4me3 and H3K27me3 distribution in naïve, TH1,
TH2, and TH17 cells, combined with global transcriptional proﬁl-
ing demonstrated that the distribution of just two histone PTMs
(H3K27me3 and H3K4me3) could provide a simple explanation
for the differences in phenotypes observed amongst these different
T cell subsets.
For example, upon differentiation from a naïve TH state into
the various TH subsets, H3K4me3 deposition was observed at sig-
nature effector gene loci within distinct TH subsets (e.g., Ifng in
TH1, Il4 in TH2, and Il17 in TH17). Moreover, H3K27me3 deposi-
tion was correlated with transcriptional shutdown of effector gene
loci that are characteristic of other TH subsets (Wei et al., 2009;
Table 1). One might have expected that changes in the epigenetic
signatures within gene loci encoding lineage-deﬁning TFs, would
simply reﬂect those observed for lineage-speciﬁc effector gene loci.
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Table 1 | Major histone methylation patterns at lineage-specific
effector gene loci in differentiated CD4+ TH populations.
TH1 TH2 TH17
Ifng H3K4me3+ H3K27me3+ H3K27me3+
Il4 H3K27me3+ H3K4me3+ H3K27me3+
Il17a H3K27me3+ H3K27me3+ H3K4me3+
For example, the gene locus encoding the TH17 TF Rorc (retinoid-
related orphan receptor-γ) was decorated with H3K27me3 in the
naïve state, and only acquired H3K4me3, and losing H3K27me3
after TH17 differentiation. In contrast, the repressive H3K27me3
signature was reinforced under TH1 and TH2 differentiation con-
ditions (Araki et al., 2009). However, this was not always the case.
The Tbx21 (TH1) and Gata3 (TH2) gene loci in naïve TH cells
were marked with both H3K4me3 and H3K27me3 (termed biva-
lent loci), and whilst these loci resolved to a permissive epigenetic
signature (H3K4me3+/H3K27me3−) under TH1 and TH2 differ-
entiation conditions, respectively, they did not acquire a repressive
epigenetic signature when differentiated into opposing lineages,
but rather maintained a bivalent state (Figure 4). Similarly, the
Tbx21 locus within TH17 cells was also maintained in a bivalent
state. In the case of TH17 cells, re-stimulation of TH17 cells in
the presence of IL-12 resulted in expression of IFN-γ and con-
version to a TH1 phenotype. This was associated with acquisition
of permissive epigenetic signatures at the IFN-γ locus and IL-
12-dependent STAT-4 and Tbx21-dependent epigenetic silencing
of the TH17 associated Rorc locus (Mukasa et al., 2010). Given
that epigenetic bivalency is considered a mechanism for poising
gene loci for rapid activation or repression, these data suggest that
CD4+ TH subsets can maintain some level of functional plasticity
despite lineage commitment. It is tempting to speculate that this
provides the immune system with inherent ﬂexibility, allowing
the redirection of pathogen-speciﬁc TH responses. In the case of
TH17 cells, it may represent a mechanism that enables switching
from a potent inﬂammatory TH17 response to a less damaging,
more controlled effector response. It also suggests that targeted
interventions that drive epigenetic reprograming of TH responses
involved in autoimmune diseases (such as TH17 in the context
of multiple sclerosis) might represent novel immunotherapeutic
targets that could lead to decreased pathology.
A number of studies have also deﬁned roles for CpG methyla-
tion in the differentiation of CD4+ T cells. For instance, regulated
deposition of CpG methylation is important for maintenance of
CD4+ T cells that have differentiated to become Tregs. Zheng
et al. (2010) showed that mice that had a conserved non-coding
sequence (CNS2) within the Foxp3 locus deleted, had wild-type
levels of Tregs in youngmice, but greatly reduced numbers in older
mice. Further, this was due to a loss of FoxP3 expression in the
peripheral Tregs, indicating a role for this TF, not just in Treg dif-
ferentiation, as described previously (reviewed in Josefowicz et al.,
2012), but also in the maintenance of the Treg phenotype. Finally,
they were able to show that FoxP3 binds to the CNS2 in Tregs, but
not in naïve CD4+ T cells, and that FoxP3 binding was dependent
on differentiation-induced demethylation of CpG sites within this
region. Thus, FoxP3 binding to CNS2, enabled by differentiation-
dependent CpG demethylation, results in a feed-forward signal
that enforces Treg fate.
ENZYMES MODULATING HISTONE MODIFICATION DURING T
CELL DIFFERENTIATION
Whilst there is a growing understanding of how changes in histone
PTMs correlate with dynamic changes in T cell effector functions,
it is less clear how the factors that write or erase these histone
PTMs are involved in directing T cell differentiation during an
immune response. Using the CD4 TH1 versus TH2 model system,
Allan et al. (2012) examined the role of the histone methyltrans-
ferase, Suv39H1, in epigenetic regulation of TH2 differentiation.
Suv39H1 speciﬁcally trimethylates H3K9 – a PTM typically asso-
ciated with transcriptional silencing of gene loci that is in turn
recognized by heterochromatin protein 1α (HP1α; Lachner et al.,
2001; Peters et al., 2001). Docking of HP1α onto H3K9me3+
gene loci in turn recruits HDAC1 and 2, and the transcriptional
repressor MBD1 (Fujita et al., 2003). In this way, H3K9 acetyla-
tion, a PTM associated with transcriptional activation, is limited.
Thus, Suv39H1-mediated trimethylation of H3K9 is an initial step
that triggers histone deacetylation and binding of transcriptional
repressor protein complexes that stably silence targeted loci.
While itwas possible to skewnaïveTH cells fromSuv39H1gene-
deﬁcient mice into the TH2 lineage in vitro, these cells could be
reprogrammed to secrete IFN-γ after re-culture in TH1-inducing
conditions. Thus, a lack of Suv39H1 resulted in an inability to sta-
bly repress TH1 effector gene expression. This appeared largely due
to an inability of Suv39H1 gene-deﬁcient TH2 cells to stably silence
the transcriptional potential of the key TH1 TF, T-bet (encoded by
Tbx21). Consistent with this, Suv39H1-deﬁcient TH2 cells exhib-
ited increased levels of histone acetylation at the Tbx21 locus.
Of particular interest was the fact that TH1 cells from Suv39H1
gene-deﬁcient mice stably repressed expression of TH2 effector
genes after re-culture in TH2-inducing conditions. This suggests
that histone PTMs, other than H3K9me3, are used to heritably
silence TH2 effector gene expression during TH1 differentiation,
or alternatively, other H3K9 methyltransferases (such as GP9a,
SETDB1/2, or Suv39H2) are utilized by TH1 cells to establish
H3K9me3 repression at TH2 gene loci. Such a hypothesis would
require selective targeting of H3K9 methyltransferases to speciﬁc
gene loci and this could potentially be facilitated via interactions
with speciﬁc TFs that bind to speciﬁc regulatory regions within
target gene loci. Such a precedent has been observed with the
demonstration that members of the T-box family of TFs serve to
recruit histone methyltransferases to signature effector gene loci
within TH1 cells to promote gene transcription (Lewis et al., 2007).
Thus, this mechanism could potentially be a way of ensuring that
only certain gene loci are targeted for silencing within either TH1
or TH2 cell subsets, thereby ensuring appropriate gene expression,
and appropriate immune function.
Taken together, these data demonstrate that Suv39H1 acts
to speciﬁcally promote TH2 lineage commitment via epigenetic
silencing (via H3K9me3 deposition) of gene loci that drive TH1
fate commitment (Figure 5). One interesting observation was the
fact that despite TH2 cells exhibiting an overall repressive signature
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FIGURE 4 | Epigenetic reprogramming within effector gene loci of CD8+
memory T cells enables rapid effector function. (A) In naïve CD8+ T
cells, effector loci such as Ifng display repressive epigenetic marks e.g.,
H3K27me3 and is inaccessible to transcriptional machinery due to the
heterochromatin structure. Upon activation, the chromatin is remodelled
whereby it acquires active epigenetic marks e.g., H3K4me3 at key effector
loci and nucleosome exit to make the loci accessible by transcriptional
machinery and RNA polymerase II (RNAp), allowing transcription. Upon
differentiation to memory CD8+ T cells, the chromatin retains the
permissive H3K4me3 mark and RNAp remains docked. (B) Upon
re-infection, the effector loci in memory CD8+ T cells is poised and can
undergo rapid transcription.
within the Tbx21 locus, there is still evidence of H3K4me3 depo-
sition at the promoter. Thus, pharmacological interventions that
block Suv39H1 activity could serve to promote Tbx21 transcrip-
tion and subsequent TH1 gene expression. The clinical relevance
was made apparent when treatment of mice with a Suv39H1
inhibitor, was able to ameliorate TH2 cell driven tissue dam-
age in a model of allergic asthma. Treatment of mice resulted
in higher numbers of TH1 T cells, and redirected the immune
response toward a less pathogenic state. This study highlights
the potential for manipulating epigenetic programing of effec-
tor T cell responses using small molecule inhibitors to either
promote immunity, in the case of vaccination, or suppress the
damage caused by inappropriate immune responses, as is found
in autoimmune disease or allergy.
EPIGENETIC CONTROL OF T CELL DEVELOPMENT
Mature, immunologically naïve CD4+ and CD8+ T cells develop
in the thymus from multipotent hematopoietic progenitors.
Within the thymus, these progenitors progress through at least
ten phenotypically distinct stages of development, before exit-
ing the thymus as mature, naïve CD4+ or CD8+ T cells
(reviewed in Rothenberg et al., 2010). Hematopoietic progen-
itor cells enter the thymus expressing neither CD4 nor CD8,
and are hence termed double-negative (DN). They then progress
through ﬁve phenotypically distinct stages of maturation (DN1,
DN2a, DN2b, DN3a, and DN3b) before up-regulating both CD4
and CD8 (termed double-positive, DP), and following further
differentiation, permanently down-regulate either CD4 or CD8
(becoming single-positive, SP), before migrating from the thymus.
Importantly, events occurring in the thymus not only determine
lineage commitment (CD4+ versus CD8+), but also the potential
fates of mature T cells; commitment to the CD8+ lineage results
in cells with specialized cytotoxic potential, while commitment to
the CD4+ lineage results in naïve cells with much broader differ-
entiation potential. Thus an interesting question is when is fate
potential programed, and what is the contribution of epigenetic
mechanisms?
Rothenberg’s group recently studied the molecular signatures
that underpin lineage commitment and differentiation occurring
in the early phases (DN1–DP) of thymic development in mice
(Zhang et al., 2012). Combining ChIP-Seq and RNA-Seq, they
determined the global distribution and dynamics of three histone
PTMs, and the transcriptional signatures of immature thymo-
cytes, at each stage of differentiation. Speciﬁcally, they studied
the distribution of H3K9/14Ac (Gett and Hodgkin, 1998; Djuretic
et al., 2007) and H3K27me3, which is enriched within the pro-
moters and enhancers of actively transcribed and repressed genes,
respectively, and H3K4me2, which deﬁnes active enhancer ele-
ments, and is often associated with transcriptionally poised gene
promoters.
Aside from highlighting the extraordinary complexity of the
mechanisms regulating T cell differentiation, this study provided
novel insights into the mechanisms controlling cellular differ-
entiation. A key ﬁnding of the paper was that the repressive
H3K27me3 PTM is often deposited at genes after transcription
has already been shutdown, indicating that the likely role of
this modiﬁcation is not to directly regulate transcription, as is
generally accepted, but rather to stabilize repression. Further,
there appeared to be multiple mechanisms of transcriptional
repression, since only approximately a third of genes that were
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FIGURE 5 | Epigenetic maintenance of TH2 lineage commitment. In the
TH2 cell subset, the master regulator of TH1 cells (Tbx21) is silenced. The
histone methylase Suv39H1 adds the repressive H3K9me3 mark at the
Tbx21 locus. This initiates recruitment and docking of heterochromatin
protein 1 alpha (HP1α), histone deacetylase (HDAC) 1 and 2, and
methyl-binding domain protein (MBD1). HDACs then remove the active
H3K9ac mark to maintain silencing, mediated by H3K9me3, at the Tbx21
locus.
developmentally repressed during thymic differentiation were
associated with H3K27me3.
In contrast, histone acetylation was strongly and temporally
correlated with mRNA levels, indicating that this modiﬁcation
may be added just prior to transcription, and as such, likely
represents a rate-limiting step in the activation of gene tran-
scription. Further histone deacetylation may be a key means of
gene repression during T cell differentiation since this observation
also implies that acetylation is either rapidly removed from pro-
moters following transcriptional repression, or is a direct cause
of transcriptional repression. Finally, H3K4me2 deposition often
preceded transcription. This ﬁnding is consistent with a previous
study showing that H3K4me2 marks lineage-speciﬁc hematopoi-
etic genes in multipotent progenitor cells, in the absence of
transcription (Orford et al., 2008). As many H3K4me2-marked
genes lost this modiﬁcation as differentiation preceded (toward an
erythroid fate), it appears that H3K4me2 poises genes for a rapid
response to differentiation signals, whereby, following the receipt
of signals, non-lineage-speciﬁc genes lose H3K4me2 and are not
expressed, while at lineage-speciﬁc genes, H3K4me2 is converted
to H3K4me3 – a positive correlate of transcription.
Taken together, these studies suggest that different histone
PTMs play distinct roles in transcriptional regulation; acetylated
histones appear to rate-limit transcription, probably by directly
regulating promoter accessibility, while H3K27me3 appears to
operate “after the fact” – stabilizing transcriptional repression
rather than directly repressing transcription. Finally, H3K4me2
apparently functions as an intermediate between unmethylated
H3K4, and the activating trimethylated state at gene promoters,
thus allowing rapid transcriptional change following differentia-
tion signals.
In the context of T cell development, CpG methylation plays
important roles both during thymic development, and in later
(peripheral) fate decisions (described above). For instance, by
deleting DNA methyltransferase 1 (DNMT1) at the DN stage of
thymic development, Lee et al. (2001) showed an ∼90% reduction
in the numbers of DP T cells, as well as large decreases in mature
peripheral T cells of both CD4+ and CD8+ lineages. Further, the
T cells that did develop had greatly reduced survival relative to
the wild-type. However, when DNMT1 was deleted at the (later)
DP stage, peripheral T cell numbers and composition were nor-
mal, but when either (Dnmt1−/−) CD4+ or CD8+ T cells where
stimulated in vitro, they had aberrant cytokine production pro-
ﬁles, in that they produced IL-2, IL-3, and IFN-γ more rapidly
than wild-type cells. This latter observation is consistent with the
demonstration that demethylation of regions controlling the tran-
scription of Ifng and Il2 in effector CD8+ T cells (Kersh et al., 2006;
Northrop et al., 2006) and Il2 in effector CD4+ T cells (Thomas
et al., 2005) coincides with their demethylation. Further, it sug-
gests that methylation might be a safeguard against inappropriate
expression of these genes, which might otherwise lead to immune
pathology. Taken together, these results indicated a central role
for DNMT1, and CpG methylation, both during thymic and post-
thymic development and differentiation of T cells of both CD4+
and CD8+ lineages.
SUMMARY
Both current effective vaccine strategies, and the design of novel
vaccine strategies that speciﬁcally target adaptive T cell immunity,
rely on acquisition and maintenance of T cell functional potential
to establish protective immunity. Conversely, these same charac-
teristics of adaptive T cell immunity are also at play during adverse
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immune reactions where priming of T cells to either environmen-
tal or self-antigens, can manifest as T cell hypersensitivities or T
cell-mediated autoimmune diseases, respectively. Thus, a greater
understanding of the molecular mechanisms, and speciﬁcally epi-
genetic mechanisms, that shape acquisition and maintenance of
lineage-speciﬁc T cell function, will be key if we are to make
advances in novel therapeutic strategies for a variety of disease
contexts. We have tried to highlight what we think are some of the
keyﬁndings and general themes emerging from the studies of T cell
differentiation, as well as the utility of the immune system as a tool
for studying differentiation and development. By comparisonwith
studies performed on stem cells, it appears that conclusions made
from studies of T cells are broadly relevant to differentiation in
other cell types and tissues. In particular, the concepts of transcrip-
tional poising andpromoter bivalency asmechanisms that regulate
fate decisions are pertinent during the differentiation of stem cells
and less primitive tissues. The studies of Rothenberg et al. (2010),
in particular, highlight the value of the immune system as a tool
for studying differentiation – because of the detailed ontogenies
and the ability to resolve different stages of T cell development
based on characteristic and deﬁned cell surface phenotypes.
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